Biotricity Inc (BTCY)
Biotricity Inc is a healthcare technology company whose common stock trades on OTC Markets under the symbol BTCY. The company develops biometric data monitoring solutions in the United States, with an emphasis on remote monitoring for medical, healthcare, and consumer applications. Its offerings span diagnostic and post-diagnostic tools designed for lifestyle and chronic conditions. Products cited by the company include Bioflux and Biocore Pro, an ECG device and software platform for cardiac outpatient monitoring, as well as Biocore for Holter and extended Holter diagnostics. Biocare supports clinicians in gathering and reviewing data for patients with multiple chronic conditions, while Bioheart and Biokit are positioned around preventive care, disease management, and remote patient monitoring for cardiac patients with additional conditions such as hypertension or COPD. Biotricity is based in Redwood City, California.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-BTCY
|
$0.11
|
56.9% Upside
|
Bargain
|
Not available
|
Not available
|
Fair
|
0.0%
|
November 20, 2026
|
0.1x
|
1.409 M
|
32.412 M
|
78.8%
|
88.1%
|
-36.1
|
-0.9%
|
-4.7%
|
